Assessment of the Efficacy of Quercetin in Adult Patients With Autism Spectrum Disorder: A Randomized, Triple-Blind, Placebo-Controlled Trial.
- 2026-07
- RCT
- Human psychopharmacology 41(4)
- Anahid Rezaeifar
- Mahtab Motamed
- Niayesh Mohebbi
- PubMed: 42438230
- DOI: 10.1002/hup.70057
- High evidence
- Clinical
The quercetin group showed a significant within-group reduction in SRS scores over time (p = 0.010), whereas the placebo group showed no significant change (p = 0.655). However, between-group differences in SRS change were not statistically significant.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No